- Dual kit for SARS-CoV-2 & Influenza A+B amongst the first of its kind to be launched in the UK.
- Self diagnostics category set to continue to grow as 46% of people in the UK said they now worry more about their health than they did pre-pandemic.
- NHS demand pushes ⅔ patients towards home-testing to get quick diagnosis. (1)
Global health-care products and solutions brand, 2San, is amongst the first companies in the UK to launch a dual kit for SARS-CoV-2 & Influenza A+B. With the ongoing demand set upon the NHS post pandemic, the over-the-counter kit has been launched to help alleviate pressures on healthcare institutions.
The single use test kit takes just ten minutes to quickly detect the SARS-CoV-2, Influenza A and Influenza B viruses that cause COVID-19 and Influenza, giving people the option to test from the comfort of their own home and to obtain a fast and accurate diagnosis.
This innovative diagnostic from 2San is indicative of the organisation’s continual investment in innovation and development of healthcare products to improve public health.
Recent research from 2San revealed that 86% of people surveyed used lateral flow tests during the pandemic, with 87% saying using them gave them reassurance of their health status. (1)
Cosima Gretton, a member of the Scientific Advisory Committee at 2San said; “This test is revolutionary in that it will allow people to determine the appropriate treatment pathway to take. it will alleviate pressure on primary healthcare institutions and it will also avoid inadvertent medical use of therapeutics or drugs that aren’t necessary.”
79% of people in the UK are interested in the option of using self-diagnostic testing to reduce the need to visit their GP for some health conditions. (1)